Inventor · disambiguated record
Zhijian Chen
Also filed as: CHEN ZHIJIAN · CHEN ZHIJIAN J · CHEN ZHIJIAN JAMES
44 granted patents·18 pending applications·100 citations·filing 1997–2025
97Inventor score
Files withIMMUNESENSOR THERAPEUTICS INC18UNIV TEXAS9LAUNCH TECH CO LTD6D3 BIO WUXI CO LTD4ALIBABA GROUP HOLDING LTD3
Top patents by PatentIndex Score
62 records- 0193US11033635B2Antibody-STING agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·3 cites·28 claims
- 0292US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 0391US10633411B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Apr 28, 2020·3 cites·30 claims
- 0490US10947206B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Mar 16, 2021·3 cites·46 claims
- 0588US12012404B2Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2023·Granted Jun 18, 2024·1 cites·30 claims
- 0687US11597707B2CGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Mar 7, 2023·1 cites·26 claims
- 0786US11492368B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2020·Granted Nov 8, 2022·1 cites·15 claims
- 0886US10519188B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2018·Granted Dec 31, 2019·6 cites·21 claims
- 0986US10508129B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Dec 17, 2019·3 cites·15 claims
- 1085US11377377B2Horizontal-vertical drain board-flocculation vacuum preloading sediment treatment methodWANG JUN·Filed 2020·Granted Jul 5, 2022·2 cites·10 claims
- 1184US10336786B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2013·Granted Jul 2, 2019·4 cites·17 claims
- 1284US2025115564A1cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1382US6107073AKinase capable of site-specific phosphorylation of IκBαMILLENNIUM PHARM INC·Filed 1997·Granted Aug 22, 2000·37 cites·11 claims
- 1482US2025115579A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1580US12134609B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Nov 5, 2024·0 cites·23 claims
- 1680US12065416B2cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·32 claims
- 1780US11475721B2Method for performing vehicle remote diagnosis and related devicesLAUNCH TECH CO LTD·Filed 2019·Granted Oct 18, 2022·3 cites·16 claims
- 1880US9421520B2Platinum/carbon nanotube catalyst, the preparation process and use thereofLI CAN·Filed 2010·Granted Aug 23, 2016·3 cites·6 claims
- 1977US10696710B2Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2019·Granted Jun 30, 2020·0 cites·16 claims
- 2077US2025154151A1Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2024·Application pending·0 cites
- 2176US12091387B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 2276US7625724B2MAVS in the prevention and treatment of viral diseasesUNIV TEXAS·Filed 2006·Granted Dec 1, 2009·2 cites·12 claims
- 2375US12281078B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·26 claims
- 2475US10748354B2Communication method, device, and system for vehicle remote diagnosisLAUNCH TECH CO LTD·Filed 2018·Granted Aug 18, 2020·3 cites·15 claims
- 2572US12311030B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted May 27, 2025·0 cites·17 claims
- 2671US11213592B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 4, 2022·0 cites·26 claims
- 2770US2022340613A1Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2868US11514731B2Method and system for remote vehicle diagnosticsLAUNCH TECH CO LTD·Filed 2019·Granted Nov 29, 2022·1 cites·15 claims
- 2968US11146664B2Method for remote vehicle diagnostics and deviceLAUNCH TECH CO LTD·Filed 2019·Granted Oct 12, 2021·1 cites·16 claims
- 3068US10990062B2Display systemBOE TECHNOLOGY GROUP CO LTD·Filed 2018·Granted Apr 27, 2021·2 cites·8 claims
- 3166US6787346B2Kinase capable of site-specific phosphorylation of IκBαMILLENNIUM PHARM INC·Filed 2002·Granted Sep 7, 2004·1 cites·6 claims
- 3265US12162880B2Pyrimidoheterocyclic compounds and application thereofD3 BIO WUXI CO LTD·Filed 2021·Granted Dec 10, 2024·0 cites·20 claims
- 3364USD679040SBicycle lampCEN LIANG·Filed 2012·Granted Mar 26, 2013·17 cites·1 claims
- 3462US2010137562A1Mavs in the prevention and treatment of viral diseaseUNIV TEXAS·Filed 2009·Application pending·0 cites
- 3560US2017296655A1Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathwayUNIV TEXAS·Filed 2017·Application pending·0 cites
- 3659US11299512B2Cyclic di-nucleotide compounds and methods of useIMMUNESENSOR THERAPEUTICS INC·Filed 2019·Granted Apr 12, 2022·0 cites·34 claims
- 3759US7452977B2Antibody to a kinase capable of site-specific phosphorylation of IκBαMILLENNIUM PHARM INC·Filed 2004·Granted Nov 18, 2008·0 cites·10 claims
- 3857US2023121320A1Sting agonist combination treatments with cytokinesIMMUNESENSOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3957US2021380695A1Sting agonist combination treatments with immune checkpoint inhibitorsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4056US9433926B2Platinum/carbon nanotube catalyst, the preparation process and use thereofDALIAN INST CHEMICAL PHYSICS CAS·Filed 2015·Granted Sep 6, 2016·0 cites·9 claims
- 4156US2025215109A1Anti-her2/anti-cd47 molecules and uses thereofWUXI BIOLOGICS IRELAND LTD·Filed 2023·Application pending·0 cites
- 4254US2023270773A1Methods of treating cancer with a sting agonistIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4354US2025282950A1Polyurethane composite material with embedded liquid healing network and preparation method thereforCHINA ACADEMY OF MACHINERY WUHAN RES INSTITUTE OF MATERIALS PROTECTION CO LTD·Filed 2025·Application pending·0 cites
- 4453US10887477B2Information exhibiting device and method and storage mediumBOE TECHNOLOGY GROUP CO LTD·Filed 2018·Granted Jan 5, 2021·0 cites·20 claims
- 4551US2004166503A1Methods for gene expression profilingFiled 2002·Application pending·0 cites
- 4650US12381538B2Calibration method and tuning method for on-chip differential active RC filterUNIV SOUTH CHINA TECH·Filed 2022·Granted Aug 5, 2025·0 cites·6 claims
- 4749US12057965B2Data communication method and apparatus, electronic device, and storage mediumLAUNCH TECH CO LTD·Filed 2022·Granted Aug 6, 2024·0 cites·18 claims
- 4848US11145418B2System and method for model-based calculation of blast exposureCFD RES CORPORATION·Filed 2019·Granted Oct 12, 2021·0 cites·20 claims
- 4948US10548538B2Electronic device and alarm control methodBOE TECHNOLOGY GROUP CO LTD·Filed 2018·Granted Feb 4, 2020·0 cites·18 claims
- 5046US2025228854A1Heterocyclic substituted pyrimidopyran compounds and their applicationsD3 BIO WUXI CO LTD·Filed 2025·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →